HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Markedly elevated levels of vascular endothelial growth factor, fibroblast growth factor, and interleukin 6 in Meigs syndrome.

Abstract
Analysis of serum and peritoneal and pleural fluid from a patient with Meigs' syndrome revealed high levels of vascular endothelial growth factor, fibroblast growth factor, and interleukin 6. Serum levels declined after removal of the ovarian tumor, along with resolution of ascites and hydrothorax. These findings suggest the involvement of these vasoactive factors in ascites and pleural fluid formation in Meigs' syndrome.
AuthorsY Abramov, S O Anteby, S J Fasouliotis, V Barak
JournalAmerican journal of obstetrics and gynecology (Am J Obstet Gynecol) Vol. 184 Issue 3 Pg. 354-5 (Feb 2001) ISSN: 0002-9378 [Print] United States
PMID11228486 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Endothelial Growth Factors
  • Interleukin-6
  • Lymphokines
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors
  • Fibroblast Growth Factors
Topics
  • Ascites (metabolism)
  • Ascitic Fluid (metabolism)
  • Endothelial Growth Factors (blood, metabolism)
  • Female
  • Fibroblast Growth Factors (blood, metabolism)
  • Histocytochemistry
  • Humans
  • Hysterectomy
  • Immunoenzyme Techniques
  • Interleukin-6 (blood, metabolism)
  • Lymphokines (blood, metabolism)
  • Meigs Syndrome (blood, metabolism, surgery)
  • Middle Aged
  • Pleural Effusion, Malignant (metabolism)
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: